Views & Analysis Looking back, looking forward – Janssen’s 60 years on the ps... Improving targeted treatments and partnering on initiatives to reduce stigma and support mental health patients.
News Ex-Novartis chief Epstein joins Remedy Pharmaceuticals David Epstein, who left his job as head of Novartis’ pharma division in May, has joined Remedy Pharmaceuticals as a special advisor.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
